PhaseBio Pharmaceuticals, Inc. (PHAS): Price and Financial Metrics
PHAS Price/Volume Stats
| Current price | $0.07 | 52-week high | $4.08 |
| Prev. close | $0.10 | 52-week low | $0.07 |
| Day low | $0.07 | Volume | 9,647,400 |
| Day high | $0.09 | Avg. volume | 848,888 |
| 50-day MA | $0.58 | Dividend yield | N/A |
| 200-day MA | $1.01 | Market Cap | 3.50M |
PHAS Stock Price Chart Interactive Chart >
PhaseBio Pharmaceuticals, Inc. (PHAS) Company Bio
PhaseBio Pharmaceuticals, Inc. engages in the development and commercialization of biotherapeutics for the treatment of orphan diseases. It focuses on cardiopulmonary disorders. The company was founded by Ashutosh Chilkoti and Clay Bernardin Thorp in January 2002 and is headquartered in Malvern, PA.
PHAS Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -97.24% |
| 5-year | -98.93% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | -22.32% |
| 2020 | -45.01% |
| 2019 | 97.73% |
Loading social stream, please wait...